136 related articles for article (PubMed ID: 14702781)
1. Biological therapy in Crohn's disease.
Gordon JN; MacDonald TT
Hosp Med; 2003 Dec; 64(12):708-12. PubMed ID: 14702781
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of Crohn's disease.
Van Deventer SJ
Scand J Immunol; 2000 Jan; 51(1):18-22. PubMed ID: 10632971
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Baert FJ; D'Haens GR; Peeters M; Hiele MI; Schaible TF; Shealy D; Geboes K; Rutgeerts PJ
Gastroenterology; 1999 Jan; 116(1):22-8. PubMed ID: 9869598
[TBL] [Abstract][Full Text] [Related]
4. Early or late guided missile in the treatment of Crohn's disease?
Caprilli R; Angelucci E; Cocco A
Dig Liver Dis; 2005 Dec; 37(12):973-9. PubMed ID: 16169305
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of Crohn's disease.
van Montfrans C; Camoglio L; van Deventer SJ
Mediators Inflamm; 1998; 7(3):149-52. PubMed ID: 9705600
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
Brookes MJ; Green JR
Drugs; 2004; 64(10):1069-89. PubMed ID: 15139787
[TBL] [Abstract][Full Text] [Related]
7. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
8. Overview of biologic therapy for Crohn's disease.
Dryden GW
Expert Opin Biol Ther; 2009 Aug; 9(8):967-74. PubMed ID: 19591627
[TBL] [Abstract][Full Text] [Related]
9. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.
Roman LI; Manzano L; De La Hera A; Abreu L; Rossi I; Alvarez-Mon M
Gastroenterology; 1996 Apr; 110(4):1008-19. PubMed ID: 8612987
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.
Middel P; Reich K; Polzien F; Blaschke V; Hemmerlein B; Herms J; Korabiowska M; Radzun HJ
Gut; 2001 Dec; 49(6):795-803. PubMed ID: 11709514
[TBL] [Abstract][Full Text] [Related]
11. "New drugs: kids come first": children should be included in trials of new biological treatments.
Cucchiara S; Morley-Fletcher A
Inflamm Bowel Dis; 2007 Sep; 13(9):1165-9; discussion 1176-7. PubMed ID: 17455208
[TBL] [Abstract][Full Text] [Related]
12. Biological therapies for inflammatory bowel diseases.
Rutgeerts P; Vermeire S; Van Assche G
Gastroenterology; 2009 Apr; 136(4):1182-97. PubMed ID: 19249397
[TBL] [Abstract][Full Text] [Related]
13. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.
Van den Brande JM; Braat H; van den Brink GR; Versteeg HH; Bauer CA; Hoedemaeker I; van Montfrans C; Hommes DW; Peppelenbosch MP; van Deventer SJ
Gastroenterology; 2003 Jun; 124(7):1774-85. PubMed ID: 12806611
[TBL] [Abstract][Full Text] [Related]
14. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
[TBL] [Abstract][Full Text] [Related]
15. Fecal bacteria from treatment-naive Crohn's disease patients can skew helper T cell responses.
Ma F; Zhang Y; Xing J; Song X; Huang L; Weng H; Wu X; Walker E; Wang Z
Exp Cell Res; 2017 Dec; 361(1):135-140. PubMed ID: 29031634
[TBL] [Abstract][Full Text] [Related]
16. Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.
García de Tena J; Manzano L; Leal JC; San Antonio E; Sualdea V; Alvarez-Mon M
J Clin Immunol; 2006 May; 26(3):233-42. PubMed ID: 16783463
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease.
Clerici M; Cassinotti A; Onida F; Trabattoni D; Annaloro C; Della Volpe A; Rainone V; Lissoni F; Duca P; Sampietro G; Fociani P; Vago G; Foschi D; Ardizzone S; Deliliers GL; Porro GB
Dig Liver Dis; 2011 Dec; 43(12):946-52. PubMed ID: 21907652
[TBL] [Abstract][Full Text] [Related]
18. Is Crohn's disease ready for fecal microbiota transplantation?
Borody TJ; Finlayson S; Paramsothy S
J Clin Gastroenterol; 2014 Aug; 48(7):582-3. PubMed ID: 24828361
[No Abstract] [Full Text] [Related]
19. T cells and cytokines in Crohn's disease.
Romagnani P; Annunziato F; Baccari MC; Parronchi P
Curr Opin Immunol; 1997 Dec; 9(6):793-9. PubMed ID: 9492980
[TBL] [Abstract][Full Text] [Related]
20. CD4 antibody treatment in Crohn's disease.
Stronkhorst A; Tytgat GN; van Deventer SJ
Scand J Gastroenterol Suppl; 1992; 194():61-5. PubMed ID: 1298050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
